The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
Open accessAbstract
Nutrient availability is the major regulator of life and reproduction, and a complex cellular signaling network has evolved to adapt organisms to fasting. These sensor pathways monitor cellular energy metabolism, especially mitochondrial ATP production and NAD + /NADH ratio, as major signals for nutritional state. We hypothesized that these signals would be modified by mitochondrial respiratory chain disease, because of inefficient NADH utilization and ATP production. Oral administration of nicotinamide riboside (NR), a vitamin B3 and NAD + precursor, was previously shown to boost NAD + levels in mice and to induce mitochondrial biogenesis. Here, we treated mitochondrial myopathy mice with NR. This vitamin effectively delayed early‐ and late‐stage disease progression, by robustly inducing mitochondrial biogenesis in skeletal muscle and brown adipose tissue, preventing mitochondrial ultrastructure abnormalities and mtDNA deletion formation. NR further stimulated mitochondrial unfolded protein response, suggesting its protective role in mitochondrial disease. These results indicate that NR and strategies boosting NAD + levels are a promising treatment strategy for mitochondrial myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“new therapeutic strategies have emerged to restore NAD+ levels in muscle by administration of dietary NAD+ precursors such as NR or NMN46,53,54”
From Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities (2019) · cites this paper as [54]
In the citing paper
“the conversion of these precursors to NAD+ bypasses the rate limited enzyme NAMPT”
From Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities (2019) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.006 · Cited by 297
RetractedTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
Self-citationAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Self-citationStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Self-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 386
Incomplete penetrance in mitochondrial optic neuropathies
Caporali, L., Maresca, A., Capristo, M., Dotto, V. D., Tagliavini, F., Valentino, M. L., Morgia, C. L., & Carelli, V. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.07.004 · Cited by 69
Mericskay, M. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.10.004 · Cited by 69
Jadeja, R. N., Powell, F. L., Jones, M. A., Fuller, J., Joseph, E., Thounaojam, M. C., Bartoli, M., & Martin, P. M. (2018) · Aging · doi:10.18632/aging.101469 · Cited by 69
Ahola, S., Auranen, M., Isohanni, P., Niemisalo, S., Urho, N., Buzková, J., Velagapudi, V., Lundbom, N. M. I., Hakkarainen, A., Muurinen, T., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606592 · Cited by 70
Self-citationMitochondrially-targeted treatment strategies
Bozi, L. H. M., Campos, J. C., Zambelli, V. O., Ferreira, N. D., & Ferreira, J. C. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100836 · Cited by 67
Sirtuins in mitochondrial stress: Indispensable helpers behind the scenes
Lin, S., Xing, H., Zang, T., Ruan, X., Wo, L., & He, M. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.03.006 · Cited by 65
Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy
Ignatenko, O., Chilov, D., Paetau, I., de Miguel, E., Jackson, C. B., Capin, G., Paetau, A., Terzioglu, M., Euro, L., & Suomalainen, A. (2018) · Nature Communications · doi:10.1038/s41467-017-01859-9 · Cited by 66
Self-citationLee, H. J., Hong, Y., Jun, W., & Yang, S. J. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3439 · Cited by 63
Fan, J., Fan, J., & Khanzada, Z. (2025) · Muscles · doi:10.3390/muscles4030026 · Cited by 65
Shi, W., Hegeman, M. A., van Dartel, D. A. M., Tang, J., Suarez, M., Swarts, H., van der Hee, B., Arola, L., & Keijer, J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600878 · Cited by 62
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
Basse, A. L., Agerholm, M., Farup, J., Dalbram, E., Nielsen, J., Ørtenblad, N., Altıntaş, A., Ehrlich, A. M., Krag, T. O. B., Bruzzone, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101271 · Cited by 61
The therapeutic perspective of NAD+ precursors in age-related diseases
Iqbal, T., & Nakagawa, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149590 · Cited by 68
Subcellular NAD+ pools are interconnected and buffered by mitochondrial NAD+
Høyland, L. E., VanLinden, M. R., Niere, M., Strømland, Ø., Sharma, S. A., Dietze, J., Tolås, I., Lucena, E., Bifulco, E., Sverkeli, L. J., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01174-w · Cited by 71
High-fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice
Wall, C. E., Whyte, J., Suh, J. M., Fan, W., Collins, B. L., Liddle, C., Yu, R. T., Atkins, A. R., Naviaux, J. C., Li, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509930112 · Cited by 61
Towards a therapy for mitochondrial disease: an update
Garone, C., & Viscomi, C. F. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180134 · Cited by 60
The Metabolic Landscape in Osteoarthritis
Wu, X., Fan, X., Crawford, R., Xiao, Y., & Prasadam, I. (2022) · Aging and Disease · doi:10.14336/ad.2021.1228 · Cited by 65
Pathophysiology of mitochondrial disease causing epilepsy and status epilepticus
Rahman, S. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.05.003 · Cited by 60
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
Nunn, A. V. W., Guy, G. W., Brysch, W., Botchway, S. W., Frasch, W. D., Calabrese, E. J., & Bell, J. D. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00204-x · Cited by 60
Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3
Mathieu, L., Costa, A. L., Bachelier, C. L., Slama, A., Lèbre, A.-S., Taylor, R. W., Bastin, J., & Djouadi, F. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.027 · Cited by 61
NAD(H) in mitochondrial energy transduction: implications for health and disease
Walker, M. A., & Tian, R. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.011 · Cited by 59
Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity
Brady, P. N., Goel, A., & Johnson, M. A. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-18 · Cited by 58
Strategies for fighting mitochondrial diseases
Viscomi, C. F., & Zeviani, M. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13046 · Cited by 58
Vignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 60
Khan, S., Ince-Dunn, G., Suomalainen, A., & Elo, L. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129202 · Cited by 59
Self-citationUmmarino, S., Mozzon, M., Zamporlini, F., Amici, A., Mazzola, F., Orsomando, G., Ruggieri, S., & Raffaelli, N. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2016.10.032 · Cited by 56
The secret messages between mitochondria and nucleus in muscle cell biology
Soledad, R. B., Charles, S., & Das, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.03.019 · Cited by 54
Yang, L., Zhu, B., Zhou, S., Zhao, M., Li, R., Zhou, Y., Shi, X., Han, J. Z., Zhang, W., & Zhou, B. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c03552 · Cited by 54
Jing, R., Corbett, J., Cai, J., Beeson, G. C., Beeson, C., Chan, S. S. L., Dimmock, D., Lazcares, L., Geurts, A. M., Lemasters, J. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.036 · Cited by 58
The Mystery of Extramitochondrial Proteins Lysine Succinylation
Chinopoulos, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116085 · Cited by 55
NAD+ metabolism-based immunoregulation and therapeutic potential
Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., Shi, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01031-5 · Cited by 55
NAD+: A key metabolic regulator with great therapeutic potential
Sultani, G., Samsudeen, A., Osborne, B., & Turner, N. A. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12508 · Cited by 54
The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases
Cantó, J., Grau‐Junyent, J. M., & Garrabou, G. (2020) · Antioxidants · doi:10.3390/antiox9100964 · Cited by 54
NAD+ Deficits in Age-Related Diseases and Cancer
Garrido, A., & Djouder, N. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.001 · Cited by 53
Loza-Medrano, S., Baiza-Gutman, L. A., Manuel‐Apolinar, L., García-Macedo, R., Damasio‐Santana, L., Martínez-Mar, O. A., Sánchez-Becerra, M. C., Cruz, M., Ibáñez-Hernández, M. Á., & Díaz-Flores, M. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05136-4 · Cited by 51
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 56
Zheng, D., Zhang, Y., Zheng, M., Cao, T., Wang, G., Zhang, L., Ni, R., Brockman, J., Zhong, H., Fan, G., et al. (2019) · Clinical Science · doi:10.1042/cs20181022 · Cited by 51
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
Sambeat, A., Ratajczak, J., Joffraud, M., Sanchez-Garcia, J. L., Giner, M. P., Valsesia, A., Giroud‐Gerbetant, J., Valera‐Alberni, M., Cercillieux, A., Boutant, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12262-x · Cited by 51
Shen, Z., Liu, P., Sun, Q., Li, Y., Acharya, R., Li, X., & Sun, C. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01683-z · Cited by 52
Seo, K.-S., Kim, J. H., Min, K.-N., Moon, J.-A., Roh, T. C., Lee, M., Lee, K., Min, J.-E., & Lee, Y. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00552 · Cited by 49
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
Barriocanal‐Casado, E., Hidalgo‐Gutiérrez, A., Raimundo, N., González‐García, P., Acuña-Castroviejo, D., Escames, G., & López, L. C. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.025 · Cited by 48
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
She, J., Sheng, R., & Qin, Z. (2021) · Aging and Disease · doi:10.14336/ad.2021.0523 · Cited by 50
Pencina, K. M., Valderrábano, R. J., Wipper, B., Orkaby, A. R., Reid, K. F., Storer, T. W., Lin, A. P., Merugumala, S. K., Wilson, L. A., Latham, N. K., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad027 · Cited by 48
Zamporlini, F., Ruggieri, S., Mazzola, F., Amici, A., Orsomando, G., & Raffaelli, N. (2014) · FEBS Journal · doi:10.1111/febs.13050 · Cited by 48
Agnew, T., Goldsworthy, M. E., Aguilar, C., Morgan, A., Simon, M., Hilton, H., Esapa, C. T., Wu, Y., Cater, H. L., Bentley, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.080 · Cited by 46
PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism
Coppi, L., Ligorio, S., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136913 · Cited by 49
Nicotinamide mononucleotide production by fructophilic lactic acid bacteria
Sugiyama, K., Iijima, K., Yoshino, M., Dohra, H., Tokimoto, Y., Nishikawa, K., Idogaki, H., & Yoshida, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-87361-1 · Cited by 46
Mitochondrial dysfunction in cognitive neurodevelopmental disorders: Cause or effect?
Anitha, A., Thanseem, I., Iype, M., & Thomas, S. V. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.002 · Cited by 47
McCormack, S. E., Polyák, E., Ostrovsky, J., Dingley, S. D., Rao, M., Kwon, Y. J., Xiao, R., Zhang, Z., Nakamaru‐Ogiso, E., & Falk, M. J. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.005 · Cited by 47
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 50
NAD+ in Cancer Prevention and Treatment: Pros and Cons
Poljšak, B. (2016) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000165 · Cited by 45
Stocks, B., Ashcroft, S. P., Joanisse, S., Dansereau, L. C., Koay, Y. C., Elhassan, Y., Lavery, G. G., Quek, L., O’Sullivan, J., Philp, A. M., et al. (2021) · The Journal of Physiology · doi:10.1113/jp280825 · Cited by 45
Thevis, M., & Schänzer, W. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7470 · Cited by 45
Agerholm, M., Dall, M., Jensen, B. A. H., Prats, C., Madsen, S., Basse, A. L., Graae, A.-S., Risis, S., Goldenbaum, J., Quistorff, B., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2017 · Cited by 42
The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease
Zou, Y., Yang, Y., Fu, X., He, X., Liu, M., Zong, T., Li, X., Aung, L. H. H., Wang, Z., & Yu, T. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.06.003 · Cited by 43
Mitochondrial Agents for Bipolar Disorder
Pereira, C. L., Chavarria, V., Vian, J., Ashton, M. M., Berk, M., Marx, W., & Dean, O. M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy018 · Cited by 41
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
Biţă, A., Scorei, I. R., Ciocîlteu, M. V., Nicolaescu, O. E., Pîrvu, A. S., Bejenaru, L. E., Rău, G., Bejenaru, C., Radu, A., Neamţu, J., et al. (2023) · Molecules · doi:10.3390/molecules28166078 · Cited by 36
Ferreira, C. R., Goorden, S. M. I., Soldatos, A. G., Byers, H. M., der Vlugt, J. M. M. G.-V., Stet, F. S., Groden, C. A., van Karnebeek, C., Gahl, W. A., Vaz, F. M., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.05.001 · Cited by 40
Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise
Ji, L. L., & Yeo, D. (2022) · Cells · doi:10.3390/cells11040710 · Cited by 44
Mitochondrial myopathies in adults and children
Pitceathly, R. D. S., & McFarland, R. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000126 · Cited by 39
The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 40
Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006756 · Cited by 40
Mitochondrial DNA replication and repair defects: Clinical phenotypes and therapeutic interventions
Roy, A., Kandettu, A., Ray, S., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148554 · Cited by 39
The function of nicotinamide phosphoribosyltransferase in the heart
Hsu, C.-P., Yamamoto, T., Oka, S., & Sadoshima, J. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.08.005 · Cited by 39
Cimaglia, G., Votruba, M., Morgan, J. E., André, H., & Williams, P. A. (2020) · Nutrients · doi:10.3390/nu12092871 · Cited by 40
Nie, H., Zhang, Y., Yu, H., Xiao, H., Li, T., & Yang, Q. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1886198 · Cited by 37
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial
McDermott, M. M., Martens, C. R., Domanchuk, K. J., Zhang, D., Peek, C. B., Criqui, M. H., Ferrucci, L., Greenland, P., Guralnik, J. M., Ho, K. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49092-5 · Cited by 37
Shi, W., Hegeman, M. A., Doncheva, A. I., Bekkenkamp‐Grovenstein, M., de Boer, V. C. J., & Keijer, J. (2019) · Nutrients · doi:10.3390/nu11102439 · Cited by 37
Improving lysosomal ferroptosis with NMN administration protects against heart failure
Yagi, M., Do, Y., Hirai, H., Miki, K., Toshima, T., Fukahori, Y., Setoyama, D., Abe, C., Nabeshima, Y., Kang, D., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302116 · Cited by 39
Mouse models for mitochondrial diseases
Ruzzenente, B., Rötig, A., & Metodiev, M. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw176 · Cited by 39
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Djouadi, F., & Bastin, J. (2019) · Cells · doi:10.3390/cells8040289 · Cited by 36
The Finnish genetic heritage in 2022 – from diagnosis to translational research
Uusimaa, J., Kettunen, J., Varilo, T., Järvelä, I. E., Kallijärvi, J., Kääriäinen, H., Laine, M., Lapatto, R., Myllynen, P. K., Niinikoski, H., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049490 · Cited by 46
Self-citationEmerging aspects of treatment in mitochondrial disorders
Rahman, S. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9855-3 · Cited by 34
Peralta, S., García, S., Yin, H. Y., Arguello, T., Díaz, F., & Moraes, C. T. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw167 · Cited by 35
Mitochondrial disorders and drugs: what every physician should know
Orsucci, D., Ienco, E. C., Siciliano, G., & Mancuso, M. (2019) · Drugs in Context · doi:10.7573/dic.212588 · Cited by 37
Tanamai, J., Veeramanomai, S., & Indrakosas, N. (2004) · PubMed · Cited by 35
Zhang, R., Sun, Y., Tian, M., Zhang, G., Feng, R., Li, X., Guo, L., Yu, X., Sun, J. Z., & He, X. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00710 · Cited by 34
Clinical syndromes associated with mtDNA mutations: where we stand after 30 years
Carelli, V., & Morgia, C. L. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170097 · Cited by 34
NAD+ precursor increases aerobic performance in mice
Crisol, B., Veiga, C. B., Braga, R. R., Lenhare, L., Baptista, I. L., Gaspar, R. C., Muñoz, V. R., Cordeiro, A. V., da Silva, A. S. R., Cintra, D. E., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02089-z · Cited by 35
The Regulatory Role of NAD in Human and Animal Cells
Kulikova, V., Gromyko, D. V., & Nikiforov, A. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070040 · Cited by 34
Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems
Kuszak, A. J., Espey, M. G., Falk, M. J., Holmbeck, M. A., Manfredi, G., Shadel, G. S., Vernon, H. J., & Zolkipli‐Cunningham, Z. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043644 · Cited by 35
Chiaratti, M. R., & Chinnery, P. F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106466 · Cited by 31
Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
Wall, C. E., Yu, R. T., Atkins, A. R., Downes, M., & Evans, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0073 · Cited by 32
Nandania, J., Gopalacharyulu, P. V., Pessia, A., Kokkonen, M. K., & Velagapudi, V. (2018) · Metabolites · doi:10.3390/metabo8030044 · Cited by 34
Self-citationNicotinamide riboside induces a thermogenic response in lean mice
Crisol, B., Veiga, C. B., Lenhare, L., Braga, R. R., Silva, V. R. R., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., Pauli, J. R., & Ropelle, E. R. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.015 · Cited by 31
Implications of NAD + boosters in translational medicine
Kang, B. E., Choi, J., Stein, S., & Ryu, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13334 · Cited by 32
Management of Leigh syndrome: Current status and new insights
Chen, L., Cui, Y., Jiang, D., Ma, C. Y., Tse, H., Hwu, W., & Lian, Q. (2017) · Clinical Genetics · doi:10.1111/cge.13139 · Cited by 32
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
Kang, Y., Hepojoki, J., Sartori-Maldonado, R., Mito, T., Terzioglu, M., Manninen, T., Kant, R., Singh, S. K., Othman, A., Verma, R., et al. (2024) · Nature · doi:10.1038/s41586-024-07260-z · Cited by 32
Self-citationToward a therapy for mitochondrial disease
Viscomi, C. F. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160085 · Cited by 30
Sonavane, M., Hayat, F., Makarov, M. V., Migaud, M. E., & Gassman, N. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242174 · Cited by 29
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
Lee, H. J., & Yang, S. J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.3 · Cited by 29
The mitohormetic response as part of the cytoprotection mechanism of berberine
Zhu, X., Wei, Y., Yang, B., Yin, X., & Guo, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-0136-8 · Cited by 29
Regulatory T cells promote adipocyte beiging in subcutaneous adipose tissue
Fang, W., Deng, Z., Benadjaoud, F., Yang, D., Yang, C., & Shi, G. (2020) · The FASEB Journal · doi:10.1096/fj.201902518r · Cited by 30
NAD Modulates DNA Methylation and Cell Differentiation
Ummarino, S., Hausman, C., Gaggi, G., Rinaldi, L., Bassal, M. A., Zhang, Y., Seelam, A. J., Kobayashi, I. S., Borchiellini, M., Ebralidze, A. K., et al. (2021) · Cells · doi:10.3390/cells10112986 · Cited by 29
Characterization of NAD salvage pathways and their role in virulence in Streptococcus pneumoniae
Johnson, M. D. L., Dao, T. H., Echlin, H., & Rosch, J. W. (2015) · Microbiology · doi:10.1099/mic.0.000164 · Cited by 27
Felici, R., Lapucci, A., Cavone, L., Pratesi, S., Palmini, R. B., & Chiarugi, A. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097204 · Cited by 28
Esterhuizen, K., Lindeque, J. Z., Mason, S., van der Westhuizen, F. H., Suomalainen, A., Hakonen, A. H., Carroll, C. J., Rodenburg, R. J., de Laat, P., Janssen, M. C. H., et al. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.02.003 · Cited by 27
Self-citationNicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans
Nascimento, E. B. M., Moonen, M. P. B., Remie, C. M. E., Gariani, K., Jörgensen, J. A., Schaart, G., Hoeks, J., Auwerx, J. H., Lichtenbelt, W. D. V. M., & Schrauwen, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa960 · Cited by 29
Self-citationExploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction
Peruzzo, R., Corrà, S., Costa, R., Brischigliaro, M., Varanita, T., Biasutto, L., Rampazzo, C., Ghezzi, D., Leanza, L., Zoratti, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22062-x · Cited by 27
Metadata
- Authors
- Khan, N. A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsström, S., Pasila, L., Velagapudi, V., Carroll, C. J., Auwerx, J., & Suomalainen, A.
- Affiliations
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- Institute for Molecular Medicine Finland (FI)
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Suomalainen, Anu
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2014-04-07
- Volume
- 6
- Issue
- 6
- Pages
- 721-731
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC4203351
- OpenAlex
- W2132438126
- Cited by
- 385
- References
- 34
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 19 · 2023: 32 · 2022: 29 · 2021: 36 · 2020: 45 · 2019: 37 · 2018: 39 · 2017: 31 · 2016: 30 · 2015: 34 · 2014: 12
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Research Council
- Saastamoinen Foundation
- Finnish Cultural Foundation
- Finnish Diabetes Foundation
- Finnish Academy
- Jane and Aatos Erkko Foundation
- Sigrid Jusélius Foundation
- Academy of Finland, and University of Helsinki
- Ecole Polytechnique Fédérale de Lausanne
- ERC
- NIH (R01HL106511‐01A, R01AG043930)
- Velux Stiftung
- Swiss National Science Foundation
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- nicotinamide riboside, mitochondrial myopathy, NAD+ precursors, NAD+/NADH ratio, mitochondrial biogenesis, mitochondrial unfolded protein response, mitochondrial DNA deletions, skeletal muscle, brown adipose tissue, mitochondrial ATP production, disease progression
- MeSH terms
- Forkhead Box Protein O1, Animals, Adipose Tissue, Brown, Energy Metabolism, Liver, Male, Mice, Inbred C57BL, Mitochondria, NAD, Niacinamide, Pyridinium Compounds, Vitamin B Complex, Mitochondrial Myopathies, Muscle, Skeletal, Lipid Metabolism, Mice, Forkhead Transcription Factors, Sirtuin 1, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
